Unlike day-trading which is based solely on technical analysis, we identify Story Trades by combining headline news, fundamental analysis, technical analysis, & social sentiment to achieve superior returns. 100% ROE in 2013. 200% in 2014.
Analyst with experience as prop trader on the Street as well as working in asset management. CFA candidate and Seeking Alpha writer. Specializing in value biotech and write Biotech Weekly. Personal opinions, not investment advice.
I'm focused primarily on undervalued Bio stocks trading @ <$10 with promising pipelines & novel therapies. My strategy employs obsessively thorough DD which helps me stay above the noise of the Street. PS: Did you know that I'm utterly insane?
A Day and Swing trader that profits off people's fear by buying that Dead Cat Bounce after the sell-offs. Plus, I go long on a few breakout plays as well. Do your own DD on any stocks I mention on my blog/tweets.